Lynne Neumayr, MD

Title(s)Clinical Professor, Pediatrics
SchoolSchool of Medicine
Address3333 California Street, #103
San Francisco CA 94118
Phone--
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abstract CT166: Similar outcomes regardless of post-randomization treatment with ibrutinib or ibrutinib + venetoclax in the phase 2 CAPTIVATE study of first-line ibrutinib + venetoclax in CLL. Cancer Research. 2023 Apr 14; 83(8_Supplement):ct166-ct166. Siddiqi ST, Tam TC, Wierda WW, Ghia GP, Kipps KT, Tedeschi TA, Gonzalez-Barca GE, Szafer-Glusman SE, Zhou ZC, Neumayr NL, Allan AJ. .
      View in: Publisher Site   Mentions:
    2. PB1878: CROSS-TRIAL ANALYSIS OF FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) VS FLUDARABINE (F), CYCLOPHOSPHAMIDE (C), AND RITUXIMAB (R) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). HemaSphere. 2022 Jun 1; 6(Suppl):1758-1759. Barrientos BJ, Barr BP, Mato MA, Tam TC, Ghia GP, Moreno MC, Kay KN, Siddiqi ST, Szafer-Glusman SE, Zhou ZC, Neumayr NL, Krigsfeld KG, Wierda WW, Shanafelt ST. .
      View in: Publisher Site   Mentions:
    3. Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial. JMIR Res Protoc. 2021 May 21; 10(5):e27650. Hood AM, Strong H, Nwankwo C, Johnson Y, Peugh J, Mara CA, Shook LM, Brinkman WB, Real FJ, Klein MD, Hackworth R, Badawy SM, Thompson AA, Raphael JL, Yates AM, Smith-Whitley K, King AA, Calhoun C, Creary SE, Piccone CM, Hildenbrand AK, Reader SK, Neumayr L, Meier ER, Sobota AE, Rana S, Britto M, Saving KL, Treadwell M, Quinn CT, Ware RE, Crosby LE. PMID: 34018965; PMCID: PMC8178738.
      View in: PubMed   Mentions: 6  
    4. Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease. Blood. 2020 Nov 5; 136(Supplement 1):26-27. Hood HA, Strong SH, Nwankwo NC, Johnson JY, Mara MC, Shook SL, Brinkman BW, Real RF, Klein KM, King KA, Calhoun CC, Smith-Whitley SK, Creary CS, Britto BM, Saving SK, Piccone PC, Raphael RJ, Volanakis VE, Hildenbrand HA, Reader RS, Rana RS, Neumayr NL, Yates YA, Badawy BS, Thompson TA, Sobota SA, Meier ME, Quinn QC, Crosby CL. .
      View in: Publisher Site   Mentions:
    5. The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD. Blood. 2020 Nov 5; 136(Supplement 1):34-36. Boye-Doe BA, Brown BE, Puri-Sharma PC, Chawla CA, Field FJ, Neumayr NL, Padrino PS, Desai DP, Manwani MD, Lanzkron LS, Little LJ. .
      View in: Publisher Site   Mentions:
    6. Differential Acetone Extraction of Total and Hemoprotein-Unbound Heme to Quantify Heme Binding Capacity of Plasma in Patients with Sickle Cell Disease: The Role of Heme Scavengers. Blood. 2020 Nov 5; 136(Supplement 1):15-15. Vissa VM, Soupene SE, Larkin LS, Neumayr NL, Vichinsky VE, Kuypers KF. .
      View in: Publisher Site   Mentions:
    7. Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management. Hematology Am Soc Hematol Educ Program. 2019 12 06; 2019(1):351-358. Adesina OO, Neumayr LD. PMID: 31808856; PMCID: PMC6913430.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease. Blood. 2019 Nov 13; 134(Supplement_1):4713-4713. Hood HA, Johnson JY, Nwankwo NC, Shook SL, Hildenbrand HA, King KA, Smith-Whitley SK, Badawy BS, Thompson TA, Creary CS, Piccone PC, Neumayr NL, Raphael RJ, Yates YA, Rana RS, Reader RS, Meier ME, Sobota SA, Crosby CL. .
      View in: Publisher Site   Mentions:
    9. Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry. Blood. 2019 Nov 13; 134(Supplement_1):2284-2284. Williams WE, Brown BE, Manwani MD, Desai DP, Field FJ, Neumayr NL, Padrino PS, Clay CE, Cong CZ, Agodoa AI, Hoppe HC, Lanzkron LS, Little LJ. .
      View in: Publisher Site   Mentions:
    10. Sickle cell disease: current treatment and emerging therapies. Am J Manag Care. 2019 11; 25(18 Suppl):S335-S343. Neumayr LD, Hoppe CC, Brown C. PMID: 31809007.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    11. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol. 2019 07; 18(7):631-642. Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmiec T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E. PMID: 31202468.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    12. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development. Hematol Oncol Clin North Am. 2019 06; 33(3):355-371. Hoppe C, Neumayr L. PMID: 31030807.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    13. Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial). Blood Adv. 2018 08 14; 2(15):1969-1979. Daak AA, Dampier CD, Fuh B, Kanter J, Alvarez OA, Black LV, McNaull MA, Callaghan MU, George A, Neumayr L, Hilliard LM, Sancilio F, Rabinowicz AL, Heeney MM. PMID: 30097463; PMCID: PMC6093734.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    14. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. PMID: 30021096.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansCTClinical Trials
    15. Systemic Biomarkers Show Elevated Oxidative Stress and Chronic Inflammation in Two Disorders of Neurodegeneration with Brain Iron Accumulation (NBIA). Blood. 2017 Dec 7; 130(Suppl_1):943-943. Minkley MM, Sweeters SN, Kasravi KS, Ferguson FJ, Higa HA, Jackson JA, Smith SD, Borchers BC, Nashmi NR, Macleod MP, Neumayr NL, Vichinsky VE, Walter WP. .
      View in: Publisher Site   Mentions:
    16. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience. Pediatr Hematol Oncol. 2017 Mar; 34(2):100-106. Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E. PMID: 28532265.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    17. Emergency department utilization by Californians with sickle cell disease, 2005-2014. Pediatr Blood Cancer. 2017 06; 64(6). Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. PMID: 28000344; PMCID: PMC5403550.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    18. Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. Br J Haematol. 2017 Jan; 176(2):300-308. Dowling MM, Quinn CT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Dlamini N, Kirkham F, Hynan LS, PFAST Investigators. PMID: 27766637; PMCID: PMC5239723.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    19. Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature. Transfusion. 2016 11; 56(11):2877-2888. Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B. PMID: 27759170.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    20. 278 Emergency Department Utilization by Californians With Sickle Cell Disease, 2005-2014. Annals of Emergency Medicine. 2016 Oct 1; 68(4):s108. Paulukonis PS, Vichinsky VE, Neumayr NL, Treadwell TM, Coates CT, Feuchtbaum FL, Hulihan HM. .
      View in: Publisher Site   Mentions:
    21. Stroke recurrence in adult sickle cell patients: it is time for action! Transfusion. 2016 05; 56(5):1001-4. Neumayr L, Vichinsky E. PMID: 27167352.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    22. Iron Level and Monocyte Morphology Predict TLR4 Expression and Reactive Oxygen Species Production Which Influences Chronic Inflammation in ß-Thalassemia. Blood. 2015 Dec 3; 126(23):950-950. Walter WP, Slater SN, Harmatz HP, Higa HA, Ng NV, Weyhmiller WM, Evans EP, Porter PJ, Sweeters SN, Price PJ, Killilea KD, Neumayr NL, Lal LA, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    23. Abstract T P369: Increased Prevalence of Potential Right-to-Left Shunting in Children with Sickle Cell Anemia and Stroke. Stroke. 2015 Feb 1; 46(suppl_1). Dowling DM, Ramaciotti RC, Kanter KJ, Osunkwo OI, Inusa IB, Iyer IR, Kwiatkowski KJ, Johnson JC, Rhodes RM, Owen OW, Strouse SJ, Quinn QC, Panepinto PJ, Neumayr NL, Sarnaik SS, Hynan HL, Plumb PP, Kirkham KF. .
      View in: Publisher Site   Mentions:
    24. 138 Iron Overload and Hemolysis Modulate Monocytes and Inflammation in ß-Thalassemia. Free Radical Biology and Medicine. 2014 Nov 1; 76:s65. Slater SN, Harmatz HP, Higa HA, Ng NV, Weyhmiller WM, Evans EP, Porter PJ, Sweeters SN, Price PJ, Manji MA, Manocha MA, Killilea KD, Lal LA, Neumayr NL, Vichinsky VE, Walter WP. .
      View in: Publisher Site   Mentions:
    25. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol. 2014 Dec; 167(5):692-6. Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E. PMID: 25209728; PMCID: PMC4577015.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    26. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014 Dec; 61(12):2271-6. Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB. PMID: 25176145.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    27. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. PMID: 24523480; PMCID: PMC3959758.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    28. Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study). Blood. 2013 Nov 15; 122(21):1014-1014. Porter PJ, Walter WP, Neumayr NL, Evans EP, Weyhmiller WM, Harmatz HP, Wood WJ, Miller MJ, Weiss WG, Yuan YQ, Wang WZ, Grosse GR, Schoennagel SB, Meerpohl MJ, Fischer FR, Nielsen NP, Seifert SM, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    29. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr; 54(4):972-81; quiz 971. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA, CDC Thalassemia Investigators. PMID: 23889533; PMCID: PMC4410835.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    30. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 2013 Sep; 98(9):1375-82. Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP. PMID: 23645695; PMCID: PMC3762093.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    31. A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease. Blood. 2012 Nov 16; 120(21):998-998. Kutlar KA, Reid RM, Taher TA, Inati IA, Abboud AM, El-Beshlawy EA, Buchanan BG, Smith SH, Ataga AK, Koshy KN, Neumayr NL, Malik MP, Alvarez AO, Ward WR, White WJ, Johnson JE, Ghalie GR. .
      View in: Publisher Site   Mentions:
    32. Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia. Blood. 2012 Nov 16; 120(21):995-995. Porter PJ, Walter WP, Neumayr NL, Evans EP, Weyhmiller WM, Harmatz HP, Wood WJ, Miller MJ, Weiss WG, Yuan YQ, Wang WZ, Grosse GR, Schoennagel SB, Meerpohl MJ, Fischer FR, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    33. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis. 2013 Feb; 50(2):99-104. Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. PMID: 23151373; PMCID: PMC3592978.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    34. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2012 Nov; 87(11):1017-21. Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP. PMID: 22887019; PMCID: PMC3904792.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    35. Transfusion Complications in Thalassemia: A Report From the Centers for Disease Control and Prevention (CDC). Blood. 2011 Nov 18; 118(21):340-340. Vichinsky VE, Neumayr NL, Trimble TS, Thompson TA, Giardina GP, Cohen CA, Coates CT, Neufeld NE, Grant GA, Boudreaux BJ. .
      View in: Publisher Site   Mentions:
    36. A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a Fetal Hemoglobin Inducer, in Patients with Sickle Cell Disease. Blood. 2011 Nov 18; 118(21):1066-1066. Kutlar KA, Inati IA, Taher TA, El-Beshlawy EA, Reid RM, Abboud AM, Smith SH, Ataga AK, Buchanan BG, Malik MP, Koshy KN, Neumayr NL, Aiello AM, Johnson JE, White WJ, Ghalie GR. .
      View in: Publisher Site   Mentions:
    37. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary? Pediatr Blood Cancer. 2012 Mar; 58(3):466-8. Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR. PMID: 21793178.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Exp Biol Med (Maywood). 2011 Apr 01; 236(4):492-504. Kanathezhath B, Mizokami M, Stanislaus S, Hounshell C, Neumayr L, Guo H, Hearst JE, Walters MC, Kuypers FA. PMID: 21454375.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    39. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. Br J Haematol. 2011 Mar; 152(6):771-6. Wang W, Brugnara C, Snyder C, Wynn L, Rogers Z, Kalinyak K, Brown C, Qureshi A, Bigelow C, Neumayr L, Smith-Whitley K, Chui DH, Delahunty M, Woolson R, Steinberg M, Telen M, Kesler K. PMID: 21275961.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    40. A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease. Blood. 2010 Nov 19; 116(21):3221-3221. Vichinsky VE, Neumayr NL, Gold GJ, Weiner WM, Kasten KJ, Truran TD, Snyder SC, Kesler KK, Hussein HA, Harrington HT, McMahon ML, Gordeuk GV, Kutlar KA, Orringer OE, De Castro DL, Field FJ, Swerdlow SP, Bessman BJ, Snyder SR, Strouse SJ, Armstrong AF. .
      View in: Publisher Site   Mentions:
    41. Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia. Blood. 2010 Nov 19; 116(21):943-943. Kutlar KA, Ataga AK, Reid RM, Blair-Britt BL, Vichinsky VE, Neumayr NL, Labotka LR, Glass GJ, Small-WIlliams SA, Keefer KJ, Shen SL, Boosalis BM, Thomson TA, Bobbitt BP, Wallis WW, Johnson JE, Berenson BR, Perrine PS. .
      View in: Publisher Site   Mentions:
    42. Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia. Blood. 2010 Nov 19; 116(21):4269-4269. Lal LA, Sweeters SN, Ng NV, Foote FD, Evans EP, Neumayr NL, Kurio KG, Harmatz HP, Porter PJ, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    43. Emergency Room Utilization by California Sickle Cell Patients During Pediatric to Adult Care Transition. Blood. 2010 Nov 19; 116(21):254-254. Paulukonis PS, Neumayr NL, Coates CT, Vichinsky VE, Feuchtbaum FL. .
      View in: Publisher Site   Mentions:
    44. A New Method of Hip Coring Decompression for the Treatment of Femoral Avascular Necrosis In Sickle Cell Disease: Perioperative Safety and Preliminary Efficacy Data. Blood. 2010 Nov 19; 116(21):264-264. Donthineni DR, Earl EJ, Neumayr NL, Hagar HR, Quirolo QK, Aguilar AC, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    45. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010 Nov; 102(11):1017-23. Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ. PMID: 21141289; PMCID: PMC4950679.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010 May 12; 303(18):1823-31. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. PMID: 20460621; PMCID: PMC2892214.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    47. Augmentation Of Hematopoietic Engraftment Without Graft Versus Host Disease By “Add-Back” Of Photochemically Treated T Lymphocytes In Mismatched Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 2010 Feb 1; 16(2):s160-s161. Kanathezhath KB, Neumayr NL, Guo GH, Walters WM, Kuypers KF. .
      View in: Publisher Site   Mentions:
    48. Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia. Blood. 2009 Nov 20; 114(22):2021-2021. Lal LA, Sweeters SN, Herz HM, Foote FD, Neumayr NL, Kurio KG, Harmatz HP, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    49. Improved Engraftment without Graft-Versus-Host Disease After MHC-Mismatched Cord Blood Transplantation with Photochemically Treated Donor Lymphocytes. Blood. 2009 Nov 20; 114(22):2425-2425. Kanathezhath KB, Mizokami MM, Neumayr NL, Guo GH, Walters WM, Kuypers KF. .
      View in: Publisher Site   Mentions:
    50. Rate of Packed Red Blood Cell Transfusion in Pediatric Patients with Severe Chronic Anemia and Normal Cardiopulmonary Status: How Slow Is Truly Necessary?. Blood. 2009 Nov 20; 114(22):3155-3155. Agrawal AA, Hsu HE, Neumayr NL, Quirolo QK, Flori FH. .
      View in: Publisher Site   Mentions:
    51. Prolonged QTc in Sickle Cell Disease: A Potential Risk Factor for Early Death?. Blood. 2008 Nov 16; 112(11):2476-2476. Lindstedt LS, Neumayr NL, Kurio KG, Morris MC, Robertson RS, Fung FE, Harmatz HP, Wood WJ, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    52. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone. 2008 Jul; 43(1):162-168. Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP, Multi-Center Iron Overload Study Group. PMID: 18430624; PMCID: PMC2500183.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    53. Neuropsychological (NP) Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Disease (SCD). Blood. 2007 Nov 16; 110(11):428-428. Vichinsky VE, Gold GJ, Rule RR, Weiner WM, Eggleston EB, Muma MA, Neumayr NL, Lieff LS, Bessman BD, Kalinyak KK, De Castro DL, Harrington HT, Hussein HA, Johnson JC, McMahon ML, Orringer OE, Rutherford RC, Armstrong AD. .
      View in: Publisher Site   Mentions:
    54. PHYSICAL THERAPY ALONE COMPARED WITH CORE DECOMPRESSION AND PHYSICAL THERAPY FOR FEMORAL HEAD OSTEONECROSIS IN SICKLE CELL DISEASE. The Journal of Bone and Joint Surgery (American). 2006 Dec 1; 88(12):2573-2582. NEUMAYR NL, AGUILAR AC, EARLES EA, JERGESEN JH, HABERKERN HC, KAMMEN KB, NANCARROW NP, PADUA PE, MILET MM, STULBERG SB, WILLIAMS WR, ORRINGER OE, GRABER GN, ROBERTSON RS, VICHINSKY VE. .
      View in: Publisher Site   Mentions:
    55. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006 Dec; 88(12):2573-82. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP, National Osteonecrosis Trial in Sickle Cell Anemia Study Group. PMID: 17142406.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    56. Left Ventricular Dysfunction in Chronically Transused Patients with Sickle Cell Anemia and Thalassemia. Blood. 2006 Nov 16; 108(11):3745-3745. Neumayr NL, Fung FE, Harmatz HP, Butensky BE, Wood WJ, Morris MC, Robertson RS, Milet MM, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    57. MRI Assessment of Pituitary Iron and Volume in Thalassemia, and Relation to Hypothalamic-Pituitary-Gonadal Axis Function (HPG): A Feasibility Study. Blood. 2006 Nov 16; 108(11):1778-1778. Wang WZ, Fischer FR, Butensky BE, Neumayr NL, Titi Singer TS, Lee LP, Chu CZ, Hunter HJ, Firebaugh FJ, Vichinsky VE, Harmatz HP. .
      View in: Publisher Site   Mentions:
    58. Reversive Loss of Pulmonary Function Induced by Acute Chest Syndrome: A Report from the National Acute Chest Syndrome Study Group (NACSG). Blood. 2005 Nov 16; 106(11):315-315. Neumayr NL, Morris MC, Wen WA, Earles EA, Robertson RS, Abboud AM, Ballas BS, Browning BI, Bellevue BR, Daeschner DC, Groncy GP, Hume HH, Iyer IR, McMahon ML, Moncino MM, Orringer OE, Swerdlow SP, Waldron15 WP, Ware WR, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    59. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct; 19(5):929-41, viii. Aguilar C, Vichinsky E, Neumayr L. PMID: 16214653.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    60. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score. Arch Phys Med Rehabil. 2005 Jul; 86(7):1369-75. Aguilar CM, Neumayr LD, Eggleston BE, Earles AN, Robertson SM, Jergesen HE, Stulberg BN, Vichinsky EP. PMID: 16003666.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    61. Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression. Blood. 2004 Nov 16; 104(11):1685-1685. Vichinsky VE, Neumayr NL, Earles EA, Aguilar AC, Robertson RS, Orringer OE, Al-Lamki AZ, Casella CJ, Wang WW, Ramirez RG, Daeschner DC, Olivieri ON, McClain MK, Grossi GM, Pegelow PC, Toledano TS, Files FB, Krisnamurti KL, Kutlar KA, Abboud AM. .
      View in: Publisher Site   Mentions:
    62. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003 Jul; 112(1 Pt 1):87-95. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, Grossi M, Grover R, McMahon L, Swerdlow P, Waldron P, Vichinsky E. PMID: 12837872.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    63. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol. 2003 Jan; 25(1):46-55. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, Iyer RV, Ware RE, Koshy M, Rackoff WR, Pegelow CH, Waldron P, Benjamin L, Vichinsky E, Acute Chest Syndrome Study Group. PMID: 12544773.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    64. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 1; 96(1):76-79. Harmatz HP, Butensky BE, Quirolo QK, Williams WR, Ferrell FL, Moyer MT, Golden GD, Neumayr NL, Vichinsky VE. .
      View in: Publisher Site   Mentions:
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Lynne's Networks
    Concepts (171)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.